OTCMKTS:CMPD CompuMed (CMPD) Stock Price, News & Analysis $3.94 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsShort Interest About CompuMed Stock (OTCMKTS:CMPD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CompuMed alerts:Sign Up Key Stats Today's Range$3.94▼$3.9450-Day Range$2.83▼$4.7052-Week Range$1.48▼$4.70VolumeN/AAverage Volume2,245 shsMarket Capitalization$5.21 millionP/E Ratio35.82Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.Read More… Receive CMPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CompuMed and its competitors with MarketBeat's FREE daily newsletter. Email Address CMPD Stock News HeadlinesCompuMed (OTCMKTS:CMPD) Shares Down 2.6% - Here's WhyDecember 13, 2024 | americanbankingnews.comCMPD investigating after deadly shooting in Uptown CharlotteNovember 6, 2024 | yahoo.comWall Street Icon: “You must get on the right side of this thing”I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.December 22, 2024 | InvestorPlace (Ad)CMPD to discuss theft ring caseAugust 24, 2024 | yahoo.comCompumed Inc.May 23, 2024 | wsj.comCompuMed, Inc.: CompuMed, FireStarter Collaborate to Further Shared Vision of Saving More Lives through Organ Donation and TransplantationMay 1, 2024 | finanznachrichten.deCompuMed, Inc. (CMPD) Stock Price, News, Quote & History - Yahoo FinanceApril 24, 2024 | finance.yahoo.comCMPD: Man arrested in California for killings of mom, 2 kids in CharlotteMarch 20, 2024 | yahoo.comSee More Headlines CMPD Stock Analysis - Frequently Asked Questions How have CMPD shares performed this year? CompuMed's stock was trading at $2.05 at the beginning of 2024. Since then, CMPD stock has increased by 92.2% and is now trading at $3.94. View the best growth stocks for 2024 here. When did CompuMed's stock split? Shares of CompuMed reverse split before market open on Saturday, May 21st 2022. The 1-25 reverse split was announced on Saturday, May 21st 2022. The number of shares owned by shareholders was adjusted after the market closes on Saturday, May 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of CompuMed? Shares of CMPD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of CompuMed own? Based on aggregate information from My MarketBeat watchlists, some other companies that CompuMed investors own include Yamana Gold (AUY) and Agnico Eagle Mines (AEM). Company Calendar Today12/22/2024Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Data processing & preparation Sub-IndustryBusiness Services Current SymbolOTCMKTS:CMPD CUSIPN/A CIKN/A Webwww.compumed.net Phone(310) 258-5000Fax310-645-5880Employees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.11 Trailing P/E Ratio35.82 Forward P/E RatioN/A P/E GrowthN/ANet Income$-30,000.00 Net Margins2.37% Pretax Margin2.29% Return on Equity4.54% Return on Assets3.27% Debt Debt-to-Equity Ratio0.05 Current Ratio2.49 Quick Ratio2.15 Sales & Book Value Annual Sales$5.84 million Price / Sales0.89 Cash Flow$0.43 per share Price / Cash Flow9.14 Book Value$2.42 per share Price / Book1.63Miscellaneous Outstanding Shares1,322,000Free Float1,031,000Market Cap$5.21 million OptionableNot Optionable Beta0.35 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report This page (OTCMKTS:CMPD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CompuMed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CompuMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.